Scholarlink

<p>This review examines the clinical trial designs in rare mutation tumors, defined as mutations occurring in ≤ 5% of specific cancer types. It discusses molecular characteristics, the impact of histological types, and the complexities of trial conduct due to tumor heterogeneity and limited patient numbers. The article explores accelerated approval pathways, adaptive trial methods like basket and telescope designs, and the use of surrogate endpoints. It underscores the significance of international collaboration and technological advancements in advancing research for these tumors. The review concludes that rare mutation tumor presents a novel prospective for oncological researches and facilitate the precision treatment of tumors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical trial design in rare mutation tumors

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月17日

查看全文
  • Yaxuan Miao,
  • Yi Li,
  • Xicheng Wang,
  • Yi Ba

摘要

This review examines the clinical trial designs in rare mutation tumors, defined as mutations occurring in ≤ 5% of specific cancer types. It discusses molecular characteristics, the impact of histological types, and the complexities of trial conduct due to tumor heterogeneity and limited patient numbers. The article explores accelerated approval pathways, adaptive trial methods like basket and telescope designs, and the use of surrogate endpoints. It underscores the significance of international collaboration and technological advancements in advancing research for these tumors. The review concludes that rare mutation tumor presents a novel prospective for oncological researches and facilitate the precision treatment of tumors.